federal_register: 2017-24948
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-24948 | Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability; Correction | Notice | The Food and Drug Administration is correcting a notice entitled "Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability" that appeared in the Federal Register of November 3, 2017. The document announced the availability of a draft guidance for industry. The document was published with the incorrect docket number. This document corrects that error. | 2017-11-17 | 2017 | 11 | https://www.federalregister.gov/documents/2017/11/17/2017-24948/controlled-correspondence-related-to-generic-drug-development-draft-guidance-for-industry | https://www.govinfo.gov/content/pkg/FR-2017-11-17/pdf/2017-24948.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration is correcting a notice entitled "Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability" that appeared in the Federal Register of November 3, 2017. The document... |